HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc
Previous close
$4.45
Day range
$4.41 - $4.59
Year range
$2.94 - $6.79
Market cap
253.35M USD
Avg Volume
203.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 8.15M | 4.42% |
Operating expense | 6.65M | -4.58% |
Net income | -15.85M | 17.12% |
Net profit margin | -194.39 | 20.62% |
Earnings per share | -0.25 | 19.35% |
EBITDA | -17.65M | 23.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 180.28M | -32.58% |
Total assets | 204.96M | -33.53% |
Total liabilities | 294.62M | -12.49% |
Total equity | -89.66M | — |
Shares outstanding | 56.55M | — |
Price to book | -2.80 | — |
Return on assets | -21.45% | — |
Return on capital | 77.03% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -15.85M | 17.12% |
Cash from operations | -18.86M | 10.21% |
Cash from investing | 35.57M | 158.02% |
Cash from financing | 49.00K | -95.34% |
Net change in cash | 16.76M | 120.63% |
Free cash flow | 82.88K | 101.56% |
About
Founded
2015
Website
Employees
112